EIF4A2 and acute myeloid leukemia: Additional MECOM fusions have been reported in pediatric patients, including MECOM-RPN1 in a patient with AML with megakaryocytic differentiation [84] and EIF4A2-MECOM in a patient with severe congenital neutropenia and secondary AML [85].